Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Clinical trial NCT07614282 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07614282
- Sponsor
- Jennifer Amengual
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.